ALLMedicine™ Dysfunctional Uterine Bleeding Center

Jun 23rd, 2021 - Hilus cell tumours is considered an uncommon branch of androgen producing neoplasms that accounts for < 5% of all ovarian tumours. They are mostly benign and have characteristic gross and microscopic features. Here we present the first case of a h...

Jan 3rd, 2020 - The aim of this systematic review is to summarize the current evidence regarding the effectiveness of hysterectomy and hysteroscopic endometrial resection in improving quality of life (QoL), sexual function and psychological wellbeing of women abn...

Jul 8th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Jul 8th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Jun 7th, 2019 - Hysterectomy for benign gynecologic diseases, especially dysfunctional uterine bleeding, is one of the most common gynecologic interventions. The uterus can be removed using abdominal, vaginal, laparoscopic, or robotic-assisted laparoscopic hyster...

Jan 17th, 2018 - This study seeks to determine if modifying the hormonal milieu of the menstrual cycle, through administration of exogenous progesterone, will improve the effectiveness of treatments for smoking cessation in women. Progesterone, a gonadal hormone, ...

Feb 18th, 2015 - This is an open-label, uncontrolled, multi-centre observational study that analyses a follow-up of 1600 women with dysfunctional uterine bleeding (idiopathic menorrhagia) over a period of one year.The patients evaluated at four visits, beginning w...

Nov 27th, 2013 - This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of the trial.

Jul 12th, 2012 - Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed i...

Jun 24th, 2005 - The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) is a multicenter, randomized clinical trial that assessed the efficacy and effectiveness of hysterectomy versus endometrial ablation (EA) for dysfunctional uter...

Mar 3rd, 2011 - A supplement to Family Practice News. Supported by an educational grant from Gynecare Worldwide, a division of Ethicon, Inc.

Abstract and Introduction Abstract Menarche is an important event during adolescence. For most girls, it marks completion of puberty and the onset of reproductive capability. Menarche usually occurs when both breast and pubic hair development are ...

Dysfunctional Uterine Bleeding or Anovulation The normal menstrual cycle usually consists of a mean interval of 28 days (± 6 days) with a mean duration of 4 days (±2 to 3 days). Normal blood loss is approximately 30 mL per cycle, with an upper lim...

Syndromes and Metabolic Disturbances Causing Endogenous Hyperandrogenemia Adrenal androgen excess, insulin resistance,[9] acne, infertility, dysfunctional uterine bleeding, and hirsutism are characteristic findings in polycystic ovary syndrome. Ob...

LAS VEGAS — Endometrial ablation as a treatment for dysfunctional uterine bleeding achieves symptom relief comparable in the short term to a hysterectomy, with less morbidity, Dr. Malcolm G.